Author:
Rho Jinhyung,Seo Chang-Seob,Park Hee-Seon,Jeong Hye-Yun,Moon Og-Sung,Seo Young-Won,Son Hwa-Young,Won Young-Suk,Kwun Hyo-Jung
Funder
Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries
Agri-Bio Industry Technology Development Program
Ministry of Agriculture, Food and Rural Affairs
MAFRA
Subject
Drug Discovery,Pharmacology
Reference48 articles.
1. Lower urinary tract symptoms, benign prostatic hyperplasia, and urinary retention;Alawamlh;Med. Clin.,2018
2. Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study;Alcaraz;Int. Urol. Nephrol.,2016
3. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia;Altavilla;Br. J. Pharmacol.,2012
4. Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low- and high-grade prostatic intraepithelial neoplasia and prostatic carcinoma;Baltaci;BJU Int.,2001
5. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis;Brentnall;BMC Cell Biol.,2013
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献